Aarti Pharmalabs approved quarterly financial results, reporting consolidated revenue of Rs. 535.80 Cr and net profit of Rs. 76.14 Cr.

The Board sanctioned a Rs. 149 Cr capex for Intermediate Block capacity expansion.

Leadership updates include Rashesh C. Gogri's shift to MD and Hetal Gogri Gala's transition to Executive Director.